论文部分内容阅读
目的观察消脂和肝胶囊联合多烯磷脂酰胆碱胶囊在维吾尔族和汉族乙型肝炎患者中的临床疗效。方法选取2014年6月至2014年12月在新疆维吾尔自治区和田地区传染病医院的300例维吾尔族乙型肝炎患者和75例汉族乙型肝炎患者进行观察,两组患者在常规基础治疗(饮食控制、增加运动量)上加用消脂和肝胶囊联合多烯磷脂酰胆碱胶囊进行治疗,观察两组患者的临床症状变化、血脂、肝功能指标等数值变化。结果维吾尔族组的治疗有效率为81%,汉族组的治疗有效率为73%,差异具有统计学意义(P=0.032);两组患者治疗前后血脂及肝功能指标等差异均有统计学意义(P<0.05)。结论消脂和肝胶囊联合多烯磷脂酰胆碱胶囊对治疗乙型肝炎具有较高的临床疗效,对维吾尔族乙型肝炎患者的临床疗效优于汉族乙型肝炎患者,能够在新疆维吾尔自治区推广使用。
Objective To observe the curative effect of Xiaozhi Hegan Capsule combined with polyene phosphatidylcholine capsule in Uygur and Han patients with hepatitis B virus. Methods 300 Uighur hepatitis B patients and 75 Han hepatitis B patients from June 2014 to December 2014 in Inhedian Infectious Diseases Hospital of Xinjiang Uygur Autonomous Region were enrolled in this study. Patients in both groups underwent routine basic treatment (diet control , Increase the amount of exercise) plus Cellulite and liver capsules combined with polyene phosphatidylcholine capsules for treatment, two groups of patients were observed changes in clinical symptoms, blood lipids, liver function and other numerical changes. Results The effective rate of treatment was 81% in Uygur group and 73% in Han group (P = 0.032). There was significant difference in the levels of blood lipid and liver function between the two groups before and after treatment (P <0.05). Conclusion Cellulite and Liver Capsule combined with polyene phosphatidylcholine capsule has a high clinical efficacy in the treatment of hepatitis B, and has a better clinical efficacy than that of Han hepatitis B patients in Uygur Hepatitis B patients and can be promoted in Xinjiang Uygur Autonomous Region use.